Ardena logo

MSAT Project Manager – Biotherapeutics Nitrosamine Assessment

Hiring from
Belgium
Work type
Hybrid
Posted

623,390 remote jobs, straight from company career pages

100% free · New jobs every minute

Show job description

About us

At Ardena, we’re helping shape the future of medicine. Our teams work on the development of innovative and complex therapies that can improve the lives of patients around the world.

As a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), Ardena partners with pharmaceutical and biotech companies to turn scientific ideas into real treatments. From early development to manufacturing and regulatory support, we help bring new medicines to market faster and with the highest quality standards.

With more than 750 colleagues across Europe and the United States, Ardena offers expertise in drug substance and drug product development, manufacturing, bioanalytical services, clinical logistics, fill & finish, and CMC regulatory support.

But what truly makes Ardena special is our people. We are a science-driven and people-focused company where collaboration, innovation, and curiosity are encouraged.

We offer an international environment where you can learn, take initiative, and grow your career across teams, functions, and locations. Our way of working is guided by our CARE values: Communicative, Accountable, Reliable, and Excellent. These values shape how we collaborate, solve challenges, and support each other every day.

At Ardena, you’re not just building your career — you’re helping build the future of medicine.

For the Ardena branch based in Gent, Belgium, our CMC Regulatory Team is looking for


Project Manager – Biotherapeutics Nitrosamine Assessment

As project manager you will coordinate the initial cross-functional assessment of nitrosamine risk for biotherapeutic products, including proteins and cell and gene therapies. The role includes an initial biotherapeutics nitrosamine assessment covering proteins and cell and gene therapies. This assignment first establishes whether existing paper-based assessments remain adequate against current regulatory expectations and identifies evidence gaps, options, indicative scope and resource needs. Confirmatory testing and remediation are not assumed. Accountable SMEs retain scientific conclusions and testing decisions.

Key Responsibilities:

  • Partner with biotherapeutics leads to identify the relevant drug substance, drug product, MSAT Material Sciences and R&D Material Sciences SMEs, keeping outreach focused on the initial assessment.

  • Establish a focused assessment workplan with clear owners, milestones, decisions and dependencies, aligned with the existing synthetics nitrosamine program and leading to an initial scope and resource estimate.

  • Under SME direction, coordinate review of existing biotherapeutics risk evaluations, assumptions and supporting evidence, including material, process, water, packaging and storage inputs.

  • Arrange targeted technical discussions and record decisions, open questions, evidence requests and follow-up actions. Facilitate comparison of assumed biotherapeutics levels against synthetics assumptions, and assumed versus measured synthetics levels.

  • Track SME conclusions on whether paper-based evaluations are sufficient. Where gaps exist, coordinate definition of any further assessment, testing or remediation needs, distinguishing lifecycle-management products from products in development.

  • Consolidate agreed findings, open questions, options, indicative scope, timing and resource needs into concise decision-ready updates with clear ownership of next steps.


Your Profile:

Required Education & Experience

  • Ph.D. in biotechnology, bioengineering, pharmaceutical sciences, or a related life sciences field, or equivalent relevant professional experience.

  • Direct, hands-on nitrosamine risk-assessment or related investigation experience for biotherapeutic products, such as proteins, monoclonal antibodies, cell and gene therapies or antibody–drug conjugates, is mandatory for the biotherapeutics assessment included in this role. General biologics experience or nitrosamine experience limited to synthetics does not meet this requirement.

  • Project management or coordination experience in a GMP biopharmaceutical environment, including cross-functional document review, action tracking, and evidence-based scope planning.

  • Working knowledge of biotherapeutic drug substance and drug product risk factors, nitrosamine assessment documentation, and the distinction between risk evaluation, confirmatory testing, and remediation.

  • Proven ability to collaborate with scientific, quality and regulatory SMEs, turn technical discussions into a clear plan and resource estimate, and navigate sensitive scope issues while respecting SMEs’ scientific and regulatory decision-making authority.

Skills & Competencies

  • Excellent written and verbal communication skills and fluency in English.

  • Proficiency in MS Office, particularly Word and Excel, with strong technical writing and documentation skills and keen attention to detail.

  • A collaborative approach and the ability to coordinate scientific, quality and regulatory contributors.

  • Strong organization, prioritization and adaptability in a dynamic environment.

  • An independent, proactive approach, eagerness to learn, analytical problem-solving skills and a strong quality focus.

  • AI savviness is a must!

What we offer:

  • Opportunity to contribute to the development of new drugs.

  • A supportive learning environment for skill development and growth.

  • Involvement in a rapidly growing international company with an intriguing services, product, and customer portfolio.

  • Dynamic working environment with friendly and collaborative colleagues.

  • Open, straightforward, and caring company culture.

  • Attractive remuneration package with extra-legal benefits such as meal vouchers and group/hospitalization insurance.

  • Flexible working hours and the possibility for partial telework.

  • Generous annual leave entitlement of 32 days.

Join us in shaping the future of drug development and be part of a team that values your contributions and personal growth. Apply now and embark on an exciting journey with us!


Ready to apply? Please click on the application button


Similar jobs

Apply for this job100% free